Actively Recruiting
Lung Cancer Screening in High-risk Black Individuals
Led by Massachusetts General Hospital · Updated on 2026-02-23
900
Participants Needed
2
Research Sites
251 weeks
Total Duration
On this page
Sponsors
M
Massachusetts General Hospital
Lead Sponsor
A
Agency for Healthcare Research and Quality (AHRQ)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this research study is to study U.S. Black individuals with a history of smoking to examine the feasibility, acceptability, and performance of low-dose computed tomography (LDCT) screening among this population. The name of the intervention used in this research study is: Low-dose computed tomography (radiologic scan) chest scan
CONDITIONS
Official Title
Lung Cancer Screening in High-risk Black Individuals
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Self-identified Black individual.
- Have a self-reported history of smoking with no restrictions on pack years or years since quitting.
- Aged between 50 and 80 years.
You will not qualify if you...
- History of lung cancer.
- Symptoms suggestive of lung cancer such as shortness of breath, becoming easily winded, or chronic cough within the last 12 weeks.
- Pneumonia or acute respiratory infection treated with antibiotics within 12 weeks prior to enrollment.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
University of Chicago
Chicago, Illinois, United States, 60637
Actively Recruiting
2
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States, 02215
Actively Recruiting
Research Team
C
Chi Fu Jeffrey Yang, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here